-
1
-
2
BIOMARKERS OF MYOCARDIAL STRESS AND FIBROSIS FOR CLINICAL OUTCOMES ASSESSMENT IN POST MYOCARDIAL INFARCTION HEART FAILURE PATIENTS
Published 2018-03-01Subjects: Get full text
Article -
3
SIGNIFICANCE OF STIMULATING GROWTH FACTOR ST2 AND NT-proBNP IN ASSESSMENT OF POSTINFARCTION REMODELING OF THE HEART
Published 2015-12-01Subjects: “…stimulating growth factor st2…”
Get full text
Article -
4
Biomarkers ST2 and interleukin 33 for assessing the severity of cardiac inflammation and fibrosis in patients with chronic heart failure
Published 2021-10-01Subjects: Get full text
Article -
5
Evaluation of the role of serum soluble ST2 as a diagnostic biomarker for cancer-associated venous thromboembolism
Published 2025-01-01Subjects: Get full text
Article -
6
Serum IL-33/ST2 Axis Expression in Acute Exacerbations of COPD: Correlation with Pulmonary Function
Published 2025-07-01Subjects: Get full text
Article -
7
Role of soluble ST2 in short-term prediction of acute heart failure in acute ST-elevation myocardial infarction
Published 2021-05-01Subjects: Get full text
Article -
8
Increased systemic sST2 in patients with end stage renal disease contributes to milder liver damage during HCV infection
Published 2020-05-01Subjects: Get full text
Article -
9
Plasma Soluble ST2 as a Prognostic Biomarker for Cardiovascular Events and Mortality in COVID-19 Patients
Published 2025-07-01Subjects: Get full text
Article -
10
Interleukin-33 and Obesity-Related Inflammation and Cancer
Published 2024-11-01Subjects: Get full text
Article -
11
Cardioprotective effects of the estrogen receptors modulators in the conditions of experimental acute myocardial infarction
Published 2017-12-01Subjects: Get full text
Article -
12
The modulating effect of circulating carbohydrate antigen 125 on ST2 and long-term recurrent morbidity burden
Published 2025-01-01Subjects: Get full text
Article -
13
Gut Microbiota‐Butyrate‐PPARγ Axis Modulates Adipose Regulatory T Cell Population
Published 2025-05-01Subjects: Get full text
Article -
14
Soluble ST2 protein as a new biomarker in patientswith precapillary pulmonary hypertension
Published 2020-09-01Subjects: Get full text
Article -
15
Clinical use of the new biomarker ST2 in patients with chronic heart failure of ischemic genesis: an exercise test
Published 2019-09-01Subjects: Get full text
Article -
16
Endogenous IL-33 inhibits apoptosis in non-small cell lung cancer cells by regulating BCL2/BAX via the ERK1/2 pathway
Published 2025-02-01Subjects: Get full text
Article -
17
ST2L promotes VEGFA-mediated angiogenesis in gastric cancer by activating TRAF6/PI3K/Akt/NF-κB pathway via IL-33
Published 2024-11-01Subjects: Get full text
Article -
18
Changes in sST2 and NT-proBNP levels predict early cardiac arrhythmia in breast cancer patients treated with anthracycline-containing chemotherapies
Published 2024-12-01Subjects: “…soluble ST2…”
Get full text
Article -
19
Interplay of ST2 downregulation and inflammatory dysregulation in hypertrophic cardiomyopathy pathogenesis
Published 2025-06-01Subjects: Get full text
Article -
20
ILC2s induce Treg but not Th2-type immunity through IL-33/ST2 pathway in pulmonary tuberculosis
Published 2024-06-01Subjects: Get full text
Article